...
首页> 外文期刊>Hepatology research: the official journal of the Japan Society of Hepatology >Neutrophil/lymphocyte ratio as a prognostic indicator of hepatic arterial infusion chemotherapy with arterial cisplatin plus continuous 5-fluorouracil
【24h】

Neutrophil/lymphocyte ratio as a prognostic indicator of hepatic arterial infusion chemotherapy with arterial cisplatin plus continuous 5-fluorouracil

机译:嗜中性粒细胞和淋巴细胞比率作为预后肝动脉灌注的指示器与动脉顺铂+化疗连续5 -氟尿嘧啶

获取原文
获取原文并翻译 | 示例
           

摘要

AimHepatic arterial infusion (HAIC) therapy may be a therapeutic option for advanced hepatocellular carcinoma (HCC) in addition to administration of sorafenib, which is the only currently established standard regimen for this disease. Survival benefit of HAIC has been reported in patients positive for antitumor response. Therefore, the prediction of antitumor response is important in decision-making for HAIC treatment.
机译:AimHepatic动脉灌注(HAIC)治疗先进的肝细胞的治疗选择癌(HCC)除了管理索拉非尼,这是唯一的目前建立了这种疾病的标准治疗方案。生存的好处HAIC已经被报道患者抗肿瘤反应阳性。因此,抗肿瘤反应的预测HAIC重要决策吗治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号